Seroatlas · Human Serome Atlas

CTDSPL

CTD small phosphatase-like protein

Also known as: C3orf8, CTDSL_HUMAN, HYA22, PSR1, RBSP3, SCP3

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
O15194
Gene
CTDSPL
Ensembl
ENSG00000144677
Chromosome
3
Canonical length
276 aa
Protein class
Enzymes, Plasma proteins, Predicted intracellular proteins
Subcellular location
Nucleoplasm,Vesicles

OverviewNCBI Gene

Predicted to enable RNA polymerase II CTD heptapeptide repeat phosphatase activity. Predicted to be involved in chromatin remodeling and regulation of transcription by RNA polymerase II. Predicted to act upstream of or within negative regulation of G1/S transition of mitotic cell cycle and negative regulation of protein phosphorylation. Located in extracellular exosome. Biomarker of lung non-small cell carcinoma. [provided by Alliance of Genome Resources, Apr 2025]

Canonical amino-acid sequenceUniProt

276 residues, UniProt reviewed canonical sequence.

>O15194|CTDSPL
     1  MDGPAIITQV TNPKEDEGRL PGAGEKASQC NVSLKKQRSR SILSSFFCCF RDYNVEAPPP
    61  SSPSVLPPLV EENGGLQKGD QRQVIPIPSP PAKYLLPEVT VLDYGKKCVV IDLDETLVHS
   121  SFKPISNADF IVPVEIDGTI HQVYVLKRPH VDEFLQRMGQ LFECVLFTAS LAKYADPVAD
   181  LLDRWGVFRA RLFRESCVFH RGNYVKDLSR LGRELSKVII VDNSPASYIF HPENAVPVQS
   241  WFDDMTDTEL LDLIPFFEGL SREDDVYSML HRLCNR

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against CTDSPL can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.4
Highest tissue expression
50 nTPM

Expression across tissuesHPA

Tissue

  • skin: 50 nTPM
  • kidney: 39 nTPM
  • blood vessel: 38 nTPM
  • colon: 31 nTPM
  • placenta: 30 nTPM
  • seminal vesicle: 30 nTPM

Single-cell type

  • podocytes: 1,302 nCPM
  • platelets: 580 nCPM
  • distal convoluted tubule cells: 545 nCPM
  • pituicytes/fscs: 425 nCPM
  • megakaryocyte progenitors: 391 nCPM
  • renal collecting duct intercalated cells: 352 nCPM

Immune cell

  • total PBMC: 2.1 nTPM
  • neutrophil: 0.4 nTPM
  • classical monocyte: 0.2 nTPM
  • naive CD4 T-cell: 0.2 nTPM
  • basophil: 0 nTPM
  • eosinophil: 0 nTPM

Brain region

  • cerebellum: 35 nTPM
  • cerebral cortex: 29 nTPM
  • basal ganglia: 27 nTPM
  • thalamus: 25 nTPM
  • amygdala: 25 nTPM
  • medulla oblongata: 24 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.96
gnomAD pLI
0
gnomAD missense Z
2.08
DepMap mean gene effect
0.07
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of CTDSPL in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads CTDSPL as an antibody target. Whether an autoantibody or antibody against CTDSPL could matter depends on whether native CTDSPL is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

CTDSPL is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label CTDSPL as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/CTDSPL. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...